Last $0.02 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

china bct pharma group inc (CNBI) Snapshot

Open
$0.02
Previous Close
$0.02
Day High
$0.02
Day Low
$0.02
52 Week High
05/1/14 - $0.25
52 Week Low
06/23/14 - $0.02
Market Cap
812.7K
Average Volume 10 Days
1.3K
EPS TTM
$0.31
Shares Outstanding
38.2M
EX-Date
--
P/E TM
0.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA BCT PHARMA GROUP INC (CNBI)

Related News

No related news articles were found.

china bct pharma group inc (CNBI) Related Businessweek News

No Related Businessweek News Found

china bct pharma group inc (CNBI) Details

China BCT Pharmacy Group, Inc., through its subsidiaries, operates as an integrated pharmaceutical company in the People’s Republic of China. It operates through three segments: Pharmaceutical Distribution, Retail Pharmacy, and Manufacturing Pharmacy. The Pharmaceutical Distribution segment purchases pharmaceutical products from suppliers and distributes them to hospitals, retail drug stores, other pharmaceutical wholesalers, clinics, medical centers, and individuals. It offers approximately 8,000 pharmaceutical and healthcare products, including branded and generic prescription medicines, over-the counter medicines, and Western and Chinese medicines, as well as personal care products and medical supplies, Chinese herbs, and medical instruments. The Retail Pharmacy segment operates a retail pharmacy network of 196 directly owned stores, primarily in Guangxi province under the Baicaotang name. The retail stores provide professional pharmaceutical services, and supply various medicines, such as prescription medicines, over-the-counter medicines, Chinese herbal medicine, roughly processed Chinese herbal medicine, family planning products, and other pharmaceutical and healthcare products. The Manufacturing Pharmacy segment manufactures and sells generic and clinic drugs, such as traditional anti-inflammatory and antibacterial drugs, cancer treatment drugs, cardio-vascular disease drugs, and hepatitis drugs under the Asio name. Its products comprise Levodopa, Tabellae Sarcandrae, Rotandine Sulfate, Corydalis Saxicola Bunting, and Ethacridine Lactate injection. The company was formerly known as China Baicaotang Medicine Limited and changed its name to China BCT Pharmacy Group, Inc. in March 2010. China BCT Pharmacy Group, Inc. is headquartered in Liuzhou, the People’s Republic of China.

1,677 Employees
Last Reported Date: 04/15/13

china bct pharma group inc (CNBI) Top Compensated Officers

Chairman of the Board and Chief Executive Off...
Total Annual Compensation: $422.5K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $322.8K
Compensation as of Fiscal Year 2012.

china bct pharma group inc (CNBI) Key Developments

China BCT Pharmacy Group, Inc. Files Form 15

China BCT Pharmacy Group, Inc. announced that it has filed Form 15 with the Securities and Exchange Commission to voluntarily deregister its common stock of par value $0.001 per share under the Securities Exchange Act of 1934, as amended.

China BCT Pharmacy Group, Inc. announced delayed 10-Q filing

On 05/16/2013, China BCT Pharmacy Group, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

China BCT Pharmacy Group, Inc. announced delayed annual 10-K filing

On 04/02/2013, China BCT Pharmacy Group, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CNBI:US $0.02 USD 0.00

CNBI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CNBI.
View Industry Companies
 

Industry Analysis

CNBI

Industry Average

Valuation CNBI Industry Range
Price/Earnings 0.1x Not meaningful
Price/Sales 0.0x Not meaningful
Price/Book 0.0x
Price/Cash Flow 0.0x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA BCT PHARMA GROUP INC, please visit www.china-bct.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.